Surgical treatment of hepatocellular carcinoma: Evidence-based outcomes

doi:10.3748/wjg.14.685

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5021)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series, Tables (1-2) series.

Item

Count

PDF

418

HTML

2884

Figures (1-9)

1451

Tables (1-2)

268

Sum=5021

Feb 7, 2008 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Feb 7, 2008; 14(5): 685-692
Published online Feb 7, 2008. doi: 10.3748/wjg.14.685

Full Size Figure Download Figure

Figure 8 Adoptive immunotherapy in HCC. Autologous lymphocytes activated in vitro with recombinant interleukin-2 and infused five times during the first month. Adoptive immunotherapy reduces recurrence and improves recurrence-free survival after surgery for HCC. Takayama et al. Lancet 2000.

Citation: Yamazaki S, Takayama T. Surgical treatment of hepatocellular carcinoma: Evidence-based outcomes. World J Gastroenterol 2008; 14(5): 685-692
URL: https://www.wjgnet.com/1007-9327/full/v14/i5/685.htm
DOI: https://dx.doi.org/10.3748/wjg.14.685